H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab - TipRanks

H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab  TipRanks